Progesterone Injection in Olive Oil With Benzyl Alcohol 10%
Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the container closure.
Yes — there is an active recall. 4 ongoing FDA recalls mention Progesterone (103 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Progesterone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the container closure.
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.
Lack of Processing Controls
Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.
Lack of Assurance of Sterility
Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.
Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.
Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.